4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia Sodium Zirconium Cyclosilicate (SZC), Enhanced dietary advice, Standard dietary advice including K+ restriction. - Hyperkalaemia | Phase 4 | Terminated | AstraZeneca | 3 | 2021-08-17 | 2023-01-19 |
| Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management Patiromer Powder for Oral Suspension [Veltassa], Placebo - Hyperkalemia | Phase 4 | Terminated | Comprehensive Research Associates | 115 | 2020-10-08 | 2023-08-31 |
| Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On Spironolactone - Type2 Diabetes, Hyperkalemia | Phase 4 | Terminated | University Hospitals Cleveland Medical Center | 8 | 2018-07-17 | 2022-05-16 |
| Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia Sodium polystyrene sulfonate, Silicified microcrystalline cellulose - Hyperkalemia | Phase 4 | Terminated | ZS Pharma, Inc. | 32 | 2013-05-01 | 2014-09-03 |
Emergencies (1)
Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Water-Electrolyte Imbalance (4) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
patiromer (2) · Bulk Drugs (1) · Spironolactone (1) · Suspensions (1) · polystyrene sulfonic acid (1) · sodium zirconium cyclosilicate (1)
AstraZeneca (1) · Comprehensive Research Associates (1) · University Hospitals Cleveland Medical Center (1) · ZS Pharma, Inc. (1)
United States (4)
Eric Wittbrodt, PharmD, MPH (1) · Henrik Rasmussen, MD (1) · Sanjay Rajagopalan, MBBS (1)